血管生成因子单独或联合超声多普勒标准对晚发型小于胎龄儿伴或不伴子痫前期进行风险分类
前瞻性队列研究纳入602例晚发型胎儿偏小孕妇,评估血管生成因子与超声多普勒参数单独或联合预测不良围产结局的价值。sFlt-1/PlGF比值单独预测价值低,但与估计胎儿体重联合时预测性能与多普勒参数联合估计胎儿体重相似;联合所有参数检出率最高,可能有助于识别即将发生的子痫前期。
要点
- 晚发型胎儿偏小中,sFlt-1/PlGF比值>第95百分位单独预测不良围产结局检出率仅39.8%,假阳性率16.9%。
- 联合估计胎儿体重<第3百分位与sFlt-1/PlGF比值>第95百分位,检出率81.3%,假阳性率52.3%。
- 联合所有参数检出率最高达88.5%,但假阳性率也最高为64.5%。
核心结论
- sFlt-1/PlGF比值单独预测不良围产结局价值低,但与估计胎儿体重联合时预测性能与估计胎儿体重联合多普勒参数相似;联合所有参数检出率最高,可能有助于识别即将发生的子痫前期;支持将血管生成因子作为现有标准之外的附加指标,但不支持作为独立生物标志物。
研究设计与样本
- 前瞻性队列研究,纳入602例单胎妊娠、晚发型胎儿偏小(出生体重<第10百分位)且分娩时孕周≥34周的孕妇;每1-2周行超声估计胎儿体重及子宫动脉搏动指数、脑胎盘率多普勒评估;诊断后1-2周内采用酶联免疫吸附法检测母体外周静脉血胎盘生长因子和可溶性fms样酪氨酸激酶-1。
诊断标准与关键数值
- 主要结局为不良围产结局复合指标(因胎儿状态不良急诊剖宫产、代谢性酸中毒(脐动脉pH<7.0)、新生儿病房入住和/或围产期死亡);预测指标包括估计胎儿体重<第3百分位、子宫动脉搏动指数>第95百分位、脑胎盘率<第5百分位、sFlt-1/PlGF比值>第95百分位。
临床应用与阅片要点
- 在晚发型胎儿偏小中,sFlt-1/PlGF比值>第95百分位单独预测不良围产结局检出率39.8%(95%CI 31.7-47.9%)、假阳性率16.9%(95%CI 10.7-23.1%);联合估计胎儿体重<第3百分位、子宫动脉搏动指数>第95百分位和脑胎盘率<第5百分位模型检出率86.8%(95%CI 83.4-90.2%)、假阳性率61.9%(95%CI 57.1-66.7%);联合估计胎儿体重<第3百分位与sFlt-1/PlGF比值>第95百分位模型检出率81.3%(95%CI 77.3-85.3%)、假阳性率52.3%(95%CI 47.1-57.5%);联合所有参数模型检出率88.5%(95%CI 85.4-91.6%)、假阳性率64.5%(95%CI 59.8-69.2%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the prognostic value of maternal angiogenic factors in late-onset small fetuses, alone or in combination with the ultrasound and Doppler parameters currently used for the classification of low-risk small-for-gestational-age (SGA) fetuses or high-risk fetal growth restriction (FGR), overall and according to the presence or absence of pre-eclampsia.
METHODS: This was a prospective cohort study of women with a singleton pregnancy with a diagnosis of late-onset fetal smallness (defined as birth weight < 10th centile) and a gestational age of ≥ 34 weeks at delivery. Ultrasound assessment of estimated fetal weight (EFW) and Doppler assessment of uterine artery pulsatility index (UtA-PI) and cerebroplacental ratio (CPR) were performed every 1-2 weeks. Biochemical analysis of the angiogenic factors placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) in maternal peripheral venous blood samples was performed using enzyme-linked immunosorbent assay within 1-2 weeks after diagnosis of SGA or FGR. The primary outcome was adverse perinatal outcome, defined as a composite of emergency Cesarean section for non-reassuring fetal status, metabolic acidosis (umbilical artery pH < 7.0), neonatal unit admission and/or perinatal death. The predictive value of EFW < 3rd centile, Doppler parameters (UtA-PI > 95th centile and CPR < 5th centile) and sFlt-1/PlGF ratio > 95th centile, alone or in combination, was assessed using logistic regression analysis in the overall population and stratified by presence or absence of pre-eclampsia developing at any time before delivery.
RESULTS: Among the 602 included cases, 91 (15.1%) developed pre-eclampsia and 511 (84.9%) did not. In the overall study population, all parameters were associated independently with adverse perinatal outcome: EFW < 3rd centile (adjusted odds ratio (aOR), 2.58 (95% CI, 1.67-4.00)), UtA-PI > 95th centile (aOR, 1.92 (95% CI, 1.25-2.94)), CPR < 5th centile (aOR, 2.35 (95% CI, 1.46-3.78)) and sFlt-1/PlGF ratio > 95th centile (aOR, 1.71 (95% CI, 1.09-2.69)). Only sFlt-1/PlGF ratio > 95th centile was associated independently with adverse perinatal outcome in cases with pre-eclampsia, whereas in those without pre-eclampsia, only EFW < 3rd centile and CPR < 5th centile were associated independently with adverse perinatal outcome. In the overall population, the detection rate (DR) and false-positive rate for adverse perinatal outcome were, respectively: 39.8% (95% CI, 31.7-47.9%) and 16.9% (95% CI, 10.7-23.1%) for sFlt-1/PlGF ratio > 95th centile alone; 86.8% (95% CI, 83.4-90.2%) and 61.9% (95% CI, 57.1-66.7%) for a combined model of EFW < 3rd centile, UtA-PI > 95th centile and CPR < 5th centile; 81.3% (95% CI, 77.3-85.3%) and 52.3% (95% CI, 47.1-57.5%) for a combined model of EFW < 3rd centile and sFlt-1/PlGF ratio > 95th centile; and 88.5% (95% CI, 85.4-91.6%) and 64.5% (95% CI, 59.8-69.2%) for a combined model including all the abovementioned observed parameters.
CONCLUSIONS: sFlt-1/PlGF ratio alone had a low predictive value for adverse perinatal outcome, but when combined with EFW, its predictive performance was similar to that of EFW combined with Doppler parameters. Combining sFlt-1/PlGF ratio with EFW and Doppler criteria achieved the highest DR for adverse perinatal outcome, and additionally, might help to identify imminent pre-eclampsia in pregnancies complicated by fetal smallness. These findings support the use of angiogenic factors as an additional criterion to those currently used for identifying high-risk FGR among late-onset small fetuses, but do not support their use as a standalone biomarker. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Youssef L, Crispi F, Paolucci S, et al. Angiogenic factors alone or in combination with ultrasound Doppler criteria for risk classification among late-onset small fetuses with or without pre-eclampsia. Ultrasound Obstet Gynecol. 2025. PMID: 39888184. doi:10.1002/uog.29181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。